Navigation Links
HealthCore presents ISPOR poster sessions
Date:5/20/2011

The verbal presentations are scheduled as follows:

SESSION I / Monday, May 23 / 8 a.m. - 8:30 p.m.

PCV106
Re-Hospitalization Rates of Acute Coronary Syndrome Patients in Real World Clinical Practice: Observations from a National Administrative Claims Data
Tunceli O1, Gandhi SK2, Bhandary D2, Stephenson JJ1, Gold A2, Fu AC1, Kern DM1, Singer J1 1HealthCore, Inc., Wilmington, Del.; 2AstraZeneca Pharmaceuticals LP, Wilmington, Del.

SESSION II / Tuesday, May 24 / 8 a.m. - 7:45 p.m.

PIN6
Trends of Hepatitis A Incidence from 2005 to 2008
Eisenberg D1, Changolkar AK2, Misurski DA2 1HealthCore, Inc., Wilmington, Del.; 2GlaxoSmithKline, Philadelphia, Pa.

PRS42
Concomitant Asthma Medication Use in Patients Using Omalizumab: Results from Three Large Insurance Claims Databases
Lafeuille MH1, Duh MS2, Zhang J3, Wertz D4, Gu T4, Tang J2, Lefebvre P1
1Groupe d'analyse, Lte, Montreal, Canada; 2Analysis Group, Inc., Boston, Mass; 3Novartis Pharmaceuticals Corporation, East Hanover, N.J/; 4HealthCore, Inc., Wilmington, Del.

SESSION III / Wednesday, May 25 / 8 a.m. 3 p.m.

PCN100
Racial Disparities in African-American Versus White Women with Newly Diagnosed Breast Cancer in a Southeast United States Health Plan
Fisher M1, Cai Q1, Paoli CJ2, Lyons A3, Wasser T1, Rodriguez N4, White S5, Kallich J3, Barron J1, Brawley OW6
1HealthCore, Inc., Wilmington, Del.,; 2University of California, San Francisco, San Francisco, Calif.; 3Amgen, Inc., Thousand Oaks, Calif.; 4Blue Cross Blue Shield of Georgia, Atlanta, Ga., 5WellPoint, Atlanta, Ga; 6American Cancer Society, Atlanta, Ga.

PGI2
Predictors of Proton Pump Inhibitor (PPI) Dosing Regimen Among Patients with Gastroesophageal Reflux Disease (GERD)
Eisenberg D1, Mody R2, Singer J1, Kamat SA1, Gerson LB3
1HealthCore, Inc., Wilmington, Del; 2Takeda Pharmaceuticals International, Inc., Deerfield, Ill.; 3Stanford University, Palo Alto, Calif.

PMH30
Indirect Costs (IC) of Adult Women with Anxiety Disorders (AD) in the United States in 2006 from the Medical Expenditures Panel Survey (MEPS)
Kavati A1, Rappaport H2
1HealthCore, Inc., Wilmington, Del; 2University of Louisiana at Monroe, Monroe, La.

PMH71
Health Care Resource Utilization (HCRU) and Direct Medical Expenditures (DME) for Adult Women with Anxiety Disorders (AD) in the United States in 2006 from the Medical Expenditures Panel Survey (MEPS)
Kavati A1, Rappaport H2
1HealthCore, Inc., Wilmington, Del.; 2University of Louisiana at Monroe, Monroe, La.

PMH78
Persistence of Stimulant Treatment in Children and Adolescents with Attention-Deficit Hyperactivity Disorder
Palli SR1, Aparasu RR2, Chen H2, Sherer JT2
1HealthCore, Inc., Wilmington, Del; 2University of Houston, Houston, Texas.

PMH79
Psychotropic Polypharmacy in Children and Adolescents with Attention Deficit / Hyperactivity Disorder
Palli SR1, Aparasu RR2, Chen H2, Sherer JT2
1HealthCore, Inc., Wilmington, Del; 2University of Houston, Houston, Texas.

PND36
Internal Locus of Control and Treatment Satisfaction with Natalizumab
Stephenson JJ1, KernDM1, Agarwal SS2, Kamat SA1
1HealthCore, Inc., Wilmington, Del.; 2Biogen Idec Inc., Weston, Mass.

PND39
Multiple Sclerosis Patients Report Improvements in Fatigue and Cognitive Functioning After One Year of Natalizumab Treatment
Stephenson JJ1, Kern DM1, Agarwal SS2, Kamat SA1
1HealthCore, Inc., Wilmington, Del.; 2Biogen Idec Inc., Weston, Mass.

PND45
One Year of Natalizumab Treatment is Associated with an Improvement in Health-related Quality of Life in Multiple Sclerosis Patients
Stephenson JJ1, Kern DM1, Agarwal SS2, Kamat SA1
1HealthCore, Inc., Wilmington, Del.; 2Biogen Idec Inc., Weston, Mass.


'/>"/>

Contact: Lori McLaughlin
lori.mclaughlin2@wellpoint.com
317-407-7403
HealthCore
Source:Eurekalert

Related medicine news :

1. AGA presents cutting-edge research during DDW
2. PI presents safety results in Neuralstem ALS Stem Cell Trial
3. Alfred B. Knight, M.D., Scott & White Healthcare, presents at 8th Annual World Health Care Congress
4. Cancer surgery society presents top honor to Kimberly Duchossois
5. Euthymics presents phase II data for EB-1010 in major depression at ACNP annual meeting
6. John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
7. Professor Zvi Ram presents phase III recurrent glioblastoma survival and quality of life data from the first pivotal study of the NovoTTF-100A at 15th Annual Society for Neuro-Oncology Scientific Meeting
8. AAPS presents awards to exemplary researchers
9. Governor presents UH researcher with grant for cardiac device
10. Onconova Therapeutics presents new data demonstrating radioprotection by Ex-RAD at RRS annual meeting
11. APA presents latest research on same-sex marriage at annual convention in San Diego
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... at the 2016 Anti-Aging & Beauty Awards at The Aesthetic & Anti-aging ... Anti-aging Medicine European Congress (AMEC) brings together the industry’s leading scientific experts, ...
(Date:12/5/2016)... ... 2016 , ... A newly released study has found that ... accuracy of placing precordial electrodes with little cognitive effort and a high degree ... studies have shown that single electrode misplacement is one of the single largest ...
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in New York City, with long-time partners The Paul Foundation, on November 10, ...
(Date:12/4/2016)... ... 03, 2016 , ... While James Earl Jones is known for myriad roles ... show called "Front Page". One of the forthcoming episodes examines mammogram techniques; a very ... in large part due to early detection. Like any other disease, treatments have a ...
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior Care Auditors® was ... Tuesday evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony and ... Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ingenuity, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec 5, 2016 Research and Markets ... Market - Global Forecast to 2021" report to their offering. ... , , ... reach 17.27 billion by 2021, at a CAGR of 5.3% from 2016 ... growing number of obesity cases, increasing government spending on healthcare, and rising ...
(Date:12/5/2016)... PharmaBoardroom today releases its new 70 page Switzerland Healthcare & Life ... , , ... stakeholders crucial insight into Switzerland ; a country located ... of the world,s most important international health institutions as well as two ... number one ranking globally in terms of ease of doing business and ...
(Date:12/4/2016)... , Dec. 4, 2016 Blueprint ... in discovering and developing targeted kinase medicines for ... from its ongoing Phase 1 trial evaluating BLU-285, ... with advanced systemic mastocytosis (SM). Blueprint Medicines is ... of D816V mutant KIT. Approximately 90 to 95 ...
Breaking Medicine Technology: